Dr. Repka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1608 N 28th Ave W
Duluth, MN 55806
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1988 - 1991
- Hennepin HealthcareResidency, Internal Medicine, 1986 - 1988
- California Pacific Medical CenterInternship, Internal Medicine, 1984 - 1985
- University of Minnesota Medical SchoolClass of 1984
Certifications & Licensure
- MN State Medical License 1985 - 2025
- WI State Medical License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
- Fellow (FACP) American College of Physicians, 1996
Clinical Trials
- Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 183 citationsIL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trialLinda J. Burns, Daniel J. Weisdorf, Todd E. DeFor, David H. Vesole, Tanya Repka
Bone Marrow Transplantation. 2003-07-01 - 161 citationsNatural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.Sarah Cooley, Linda J. Burns, Tanya Repka, Jeffrey S. Miller
Experimental Hematology. 1999-10-01 - 138 citationsEffect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes.Mark D. Scott, J. J. M. Van Den Berg, T. Repka, Philippe Rouyer-Fessard, R. P. Hebbel
The Journal of Clinical Investigation. 1993-04-01
Grant Support
- Herceptin &Il-2 For Treatment Of Her/Neu Positive CanceNational Center For Research Resources2000–2002
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: